Last reviewed · How we verify
NCT05340114
Usability Study of CEREBO® - A Novel Non-invasive Intracranial Bleed Detector
NA trial testing CEREBO® in Traumatic Brain Injury in 10 participants. Status unknown.
30 April 2023
Quick facts
| Lead sponsor | Bioscan Research Pvt. Ltd. |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 10 |
| Start date | 25 April 2022 |
| Primary completion | 30 April 2023 |
| Estimated completion | 31 May 2023 |
Drugs / interventions tested
- CEREBO®
Conditions studied
- Traumatic Brain Injury — all drugs for Traumatic Brain Injury →
- Intracranial Hemorrhages — all drugs for Intracranial Hemorrhages →
Sponsor
Bioscan Research Pvt. Ltd.
Who can join
18 and older, any sex, with Traumatic Brain Injury or Intracranial Hemorrhages. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Traumatic Brain Injury (TBI) is the leading cause of death and disability across the globe. Time from injury to treatment is the most critical factor that determines the patient's recovery. Mild TBI with no apparent symptoms are often left undiagnosed, thus delaying the treatment and hence recovery. CEREBO® is a non-invasive, rapid, near-infrared based, point-of-care device that can detect an intracranial bleed at an early stage.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05340114
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CEREBO®
Trials testing the same drug.
- NCT05340127 — Summative Usability Study of CEREBO® - a Non Invasive Intracranial Hemorrhage Detector · NA · unknown
Other recruiting trials for Traumatic Brain Injury
Currently open trials in the same condition.
- NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation · NA · recruiting
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
- NCT07455136 — A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Mon · recruiting
- NCT07404761 — Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments · NA · recruiting
- NCT07230002 — Effects of Moderate/Severe Traumatic Brain Injury in the Subacute or Chronic Phase on Locomotor Strategies Involved in N · NA · recruiting
Other Bioscan Research Pvt. Ltd. trials
Trials by the same sponsor.
- NCT05340127 — Summative Usability Study of CEREBO® - a Non Invasive Intracranial Hemorrhage Detector · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05340114 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bioscan Research Pvt. Ltd.
- Last refreshed: 21 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05340114.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing